Blood Analyzers in Pennsylvania

Saladax Biomedical, Inc. is a biotechnology company specializing in therapeutic drug monitoring (TDM) assays for psychiatry and oncology. The company develops and manufactures rapid blood-level measurement tests that optimize drug dosing for essential medications prescribed by psychiatrists and oncologists. Key products include the My5-FU Assay for monitoring 5-Fluorouracil chemotherapy (Health Canada approved, May 2024) and MyCare™ Insite for clozapine monitoring with point-of-care testing capabilities, delivering results in hours rather than days. Saladax supports personalized medicine initiatives through companion diagnostics and clinical trial collaborations with pharmaceutical partners. The company's TDM solutions enable clinicians to confirm medication adherence, optimize dosing regimens, and reduce toxicity risks, improving patient outcomes in psychiatric and oncological care. International distribution partnerships expand access across multiple regions.

CHRONO-LOG CORP. designs, develops, and manufactures innovative platelet function testing systems for clinical and research laboratories. The company specializes in platelet aggregation and secretion methodologies used to diagnose platelet function defects, monitor anti-platelet drug therapy, and identify bleeding or thrombotic risk in patients. CHRONO-LOG offers three primary testing platforms: Whole Blood/Impedance Aggregation for rapid platelet function screening in physiologic whole blood environments with reduced sample preparation; Optical/Light Transmission Aggregation (LTA) using dual-beam detection for improved sensitivity with micro-volume samples (250 µL); and ATP Release analysis for quantitative measurement of dense granule secretion and simultaneous aggregation-secretion studies. The company also provides Ristocetin CoFactor Assay systems for Von Willebrand Disease diagnosis, with capabilities to detect Type 3 disease at 3% activity levels. CHRONO-LOG systems are used to diagnose specific platelet disorders including Von Willebrand Disease, Glanzmann's Thrombasthenia, Storage Pool Disease, and secretion defects. The platform supports PRP, washed, and gel-filtered platelet testing. CHRONO-LOG's aggregation systems and reagents are FDA-cleared and CE-marked. The company serves hematology, hemostasis, and thrombosis laboratories globally, supporting patient risk stratification, anti-platelet drug selection and monitoring, and research into novel hemostatic therapies. CHRONO-LOG emphasizes reduced blood draw volumes, faster turnaround times, and lower labor intensity compared to alternative platelet function testing methods.

Fujirebio Holdings, Inc. is a subsidiary of H.U. Group Holdings Inc. that specializes in in vitro diagnostics (IVD) biomarker innovation and Contract Development & Manufacturing Organization (CDMO) services. The company drives the biomarker-to-IVD journey through research, clinical validation, and manufacturing partnerships, with a focus on transformative diagnostic solutions across multiple disease areas. Fujirebio's core offering includes the Lumipulse® platform, a fully automated immunoassay system for clinical laboratory testing, alongside manual and semi-automated assay kits (INNO-LIA®, INNO-LiPA®, INNOTEST®, CanAg®). The company manufactures diagnostic instruments, assay kits, software (LIRAS®), quality controls, and raw materials (antibodies and antigens). Primary clinical specialties include neurodegeneration (Alzheimer's disease, multiple sclerosis, Parkinson's disease, ALS), with blood-based biomarkers for amyloid and phosphorylated tau; infectious diseases (HPV genotyping, HPV screening); autoimmune disorders; cardiac markers; tumor markers; fertility and endocrinology; diabetes; and bone metabolism. Recent FDA clearances include blood-based Alzheimer's disease diagnostic tests. The company maintains regulatory credentials including FDA 510(k) clearances and CE marking. Fujirebio operates globally with CDMO partnerships, providing diagnostic raw materials, reagents, and full development and manufacturing services to technology partners and clinical laboratories.

J.P. Gilbert Co. manufactures and services the Hemaprep® and Miniprep® automated blood smearing instruments. These devices are designed for clinical laboratory applications, automating the preparation of blood smears for microscopic analysis. The company provides both equipment sales and comprehensive parts/service support to healthcare facilities and laboratory settings.